# 4D Molecular Therapeutics: Biotechnology, Emeryville, United States

> 4D Molecular Therapeutics: 4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical...

Source: https://millionrounds.com/startup/4d-molecular-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# 4D Molecular Therapeutics

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

Funding reported Last round: Post ipo equity

Biotechnology Emeryville, United States

Company summary

- **Founded:** 2015 11 years old
- **Team:** 101 51 to 200 people
- **Funding reported:** $595M in dollars
- **Last round:** Post ipo equity Feb 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for 4D Molecular Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say 4D Molecular Therapeutics raised

Funding, as reported

Reported in all **$595M** in dollars

Rounds **6**

Last round **Post ipo equity**

Last round date **Feb 2024**

Investors listed **19**

SEC Form D **$109M sold, 3 filings, last Sept 2018**

## Founders and team

From 4D Molecular Therapeutics's own website and the SEC filings it signed: 1 founder, 9 on the team.

**Theresa Janke** Chief of Staff, Co-Founder *Named on its 2018 Form D*

- **Chris Simms** Chief Commercial & Business Officer
- **Kim Maplestone** Chief Clinical Operations Officer
- **Kristian Humer** Chief Financial Officer
- **Glenn P. Sblendorio** Board Member
- **Nancy Miller-Rich** Board Member
- **David Kirn** Executive Officer, Director i
- **David Schaffer** Executive Officer, Director i
- **Leisa Johnson** Executive Officer i
- **Peter Francis** Executive Officer i

On the board, as filed i *Charles Theuer* *Hoyoung Huh* *Margi McLaughlin* *Tony Yao*

## On 3 portfolio pages

Investors who name them

- [Berkeley Catalyst Fund](https://millionrounds.com/fund/berkeley-catalyst-fund)
- [Longevity Vision](https://millionrounds.com/fund/longevity-vision)
- [Amzak Health](https://millionrounds.com/fund/amzak-health)

Each firm lists 4D Molecular Therapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biotechnology in United States

Startups like it

- [**Sojournix** Waltham · founded 2016 *Raised*](https://millionrounds.com/company/sojournix)
- [**Receptor Life Sciences** Seattle · founded 2017 *Raised*](https://millionrounds.com/company/receptor-life-sciences)
- [**Attune Pharmaceuticals** New York · founded 2018 *Raised*](https://millionrounds.com/company/attune-pharmaceuticals)
- [**AbbVie** North Chicago · founded 2012](https://millionrounds.com/startup/abbvie-2)
- [**Grail** Menlo Park · founded 2015](https://millionrounds.com/startup/grail-3)
- [**EQRx** Cambridge · founded 2019](https://millionrounds.com/startup/eqrx)
- [**Cerevel Therapeutics** Boston · founded 2018](https://millionrounds.com/startup/cerevel-therapeutics)
- [**Royalty Pharma** New York · founded 1996](https://millionrounds.com/startup/royalty-pharma)

## Is this your company?

Add your raise, your deck and your story, and put 4D Molecular Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)